FDA Updates Adverse Events With SynCardia TAH-t Drivers FDA Updates Adverse Events With SynCardia TAH-t Drivers

The 3-month rates of death and some strokes in patients using one model of the temporary total artificial heart ' s driver mechanism appear raised at 42 months in its ongoing postapproval study.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news